Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • PAFR
    (1)
  • Platelet aggregation
    (1)
  • iGluR
    (1)
  • Others
    (1)
TargetMol | Tags By ResearchField
  • Nervous System
    (1)
Filter
Search Result
Results for "

hypoxic-ischemic

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    3
    TargetMol | All_Pathways
  • Recombinant Protein
    1
    TargetMol | Recombinant_Protein
  • P7C3-A20
    T24231235481-90-9
    P7C3-A20, a derivative of P7C3, exhibits both proneurogenic and neuroprotective activities (brackets).
    • $29
    In Stock
    Size
    QTY
  • Rocepafant
    LAU-8080, LAU8080, LAU 8080, BN-50730, BN50730, BN 50730
    T28607132579-32-9In house
    Rocepafant (LAU8080) is a platelet-activating factor (PAF) antagonist that attenuates hypoxic-ischemic brain damage in neonatal rats.Rocepafant inhibits tumor necrosis factor-Afa-mediated cytotoxicity in mouse L929 tumor cells.
    • $46
    In Stock
    Size
    QTY
  • Nitromemantine
    YQW-036, NMI-6979, NitroSynapsin
    T214187765890-91-3
    Nitromemantine (NitroSynapsin) is a nitrate ester derivative of Memantine and acts as a bifunctional NMDAR antagonist. It demonstrates significant efficacy in rodent models of cerebral infarction through a dual mechanism of open channel blockade and NO/redox modulation of receptors. Under hypoxic conditions, Nitromemantine specifically targets ischemic neurons, enhancing its activity. It inhibits NMDA-induced currents with an IC50 of 2.4 μM and is utilized in the study of ischemic stroke.
    • Inquiry Price
    10-14 weeks
    Size
    QTY